Application of Electrical Impedance Tomography in Evaluating Pulmonary Function Improvement After High Lateral Recumbent Position Therapy in ARDS Patients
1 other identifier
interventional
140
0 countries
N/A
Brief Summary
This randomized controlled trial investigates the effects of prone positioning versus lateral positioning at different angles (30°, 90°, 120°) on pulmonary function improvement in patients with acute respiratory distress syndrome (ARDS). Utilizing electrical impedance tomography (EIT) technology, the study monitors key parameters including ventilation distribution and ventilation-perfusion matching in real time, while integrating respiratory mechanics and blood gas analysis data to comprehensively evaluate the therapeutic efficacy of positional adjustments. The study hypothesizes that high-angle lateral positioning may reduce adverse complications associated with prone positioning while effectively improving oxygenation and pulmonary function. The ultimate objective is to provide a safer and more personalized positional therapy regimen for clinical practice, optimizing ARDS treatment strategies to reduce mortality and enhance patient survival outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2026
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2026
CompletedFirst Submitted
Initial submission to the registry
January 22, 2026
CompletedFirst Posted
Study publicly available on registry
January 29, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
January 29, 2026
January 1, 2026
1.9 years
January 22, 2026
January 22, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
death
One month after treatment
Secondary Outcomes (4)
A/P Ratio
24 hours before treatment, 24 hours after treatment
Ventilation-Perfusion Ratio
24 hours before treatment, 24 hours after treatment
Oxygenation index
24 hours before treatment, 24 hours after treatment
Global Inhomogeneity Index, GI
24 hours before treatment, 24 hours after treatment
Study Arms (4)
90-degree high lateral position group
EXPERIMENTALPlace the patient in the 90-degree high lateral position.
30-degree low lateral position group
EXPERIMENTALPlace the patient in the 30-degree low lateral position.
120-degree high lateral position group
EXPERIMENTALPlace the patient in the 120-degree high lateral position.
Prone position group
ACTIVE COMPARATORPatients will be placed in the prone position, i.e., lying face down.
Interventions
For the 30° lateral recumbent position group, patients will be rotated between left and right lateral recumbent positions at the corresponding angles every 2 hours, spending 8 hours on each side for a total treatment duration of 16 hours. During each rotation, the nursing team will ensure the patient is safely transferred from one side to the other while maintaining the prescribed lateral angle. Wedge pillows or specialized turning pads will be used to assist in positioning, with supports placed beneath the patient's back and buttocks to alleviate pressure points. Translated with DeepL.com (free version)
For the 120° lateral recumbent position group, patients will be rotated between corresponding lateral recumbent positions on the left and right sides every 2 hours, spending 8 hours on each side for a total treatment duration of 16 hours. During each rotation, the nursing team will ensure the patient is safely transferred from one side to the other while maintaining the prescribed lateral angle. Wedge pillows or specialized turning pads will be used to assist in positioning, with supports placed under the patient's back and buttocks to alleviate pressure points. Translated with DeepL.com (free version)
For the 90° lateral recumbent position group, patients will be rotated between corresponding lateral recumbent positions on the left and right sides every 2 hours, spending 8 hours on each side for a total treatment duration of 16 hours. During each rotation, the nursing team will ensure the patient is safely transferred from one side to the other while maintaining the prescribed lateral angle. Wedge pillows or specialized turning pads will be used to assist in positioning, with supports placed beneath the patient's back and buttocks to alleviate pressure points.
Patients will be positioned in the prone position, lying face down, with specialized prone positioning devices or pillows supporting the head and chest to ensure airway patency. Daily prone therapy duration is set according to clinical guidelines, typically lasting 16 hours.
Eligibility Criteria
You may qualify if:
- Age \>= 18 years.
- Diagnosis of ARDS according to the Berlin Definition (2023 update).
- Clinically evaluated as suitable for positional therapy by physicians.
- Signed informed consent obtained from the patient or legal representative.
- Absence of severe spinal deformities or musculoskeletal disorders that may compromise safe high lateral positioning.
- No severe skin conditions (e.g., extensive open wounds or pressure ulcers) that may affect the feasibility of lateral positioning.
You may not qualify if:
- Pregnant or lactating women.
- Severe cardiac diseases (e.g., unstable arrhythmia or heart failure) that may worsen with positional changes.
- Severe coagulation disorders with increased bleeding risk.
- Known allergy to the EIT device or any of its components.
- Severe psychiatric disorders impairing study compliance.
- Current participation in experimental therapies that may affect pulmonary function.
- Severe active infections requiring special isolation measures.
- Anticipated need for emergency surgery or life-threatening complications within 24 hours.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 22, 2026
First Posted
January 29, 2026
Study Start
January 1, 2026
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
January 29, 2026
Record last verified: 2026-01